• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类成为新的小白鼠:择期手术作为多器官功能障碍和脓毒症的关键转化模型。

Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis.

作者信息

Cain David J, Del Arroyo Ana Gutierrez, Ackland Gareth L

机构信息

Clinical Physiology, Department of Medicine, University College London, London, UK.

出版信息

J Intensive Care Soc. 2015 May;16(2):154-163. doi: 10.1177/1751143714564826. Epub 2015 Jan 7.

DOI:10.1177/1751143714564826
PMID:28979398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5606478/
Abstract

Translational research in critically ill human patients presents many methodological challenges. Diagnostic uncertainty, coupled with poorly defined comorbidities, make the identification of a suitable control population for case-control investigations an arguably insurmountable challenge. Healthy volunteer experiments using endotoxin infusion as an inflammatory model are methodologically robust, but fail to replicate the onset of, and diverse therapeutic interventions associated with, sepsis/trauma. Animal models are also limited by many of these issues. Major elective surgery addresses many of these shortfalls and offers a key model for exploring the human biology underlying the sepsis syndrome. Surgery triggers highly conserved features of the human inflammatory response that are common to both tissue damage and infection. Surgical patients sustain a predictable and relatively high incidence of sepsis, particularly within the 'higher risk' group. The collection of preoperative samples enables each patient to act as their own control. Thus, the surgical model offers unique and elegant experimental design features that provide an important translational bridge between the basic biological understanding afforded by animal laboratory models and the de novo presentation of human sepsis.

摘要

危重症患者的转化研究面临诸多方法学挑战。诊断的不确定性,再加上合并症定义不明确,使得为病例对照研究确定合适的对照人群成为一项几乎无法克服的挑战。以内毒素输注作为炎症模型的健康志愿者实验在方法学上很可靠,但无法复制脓毒症/创伤的发病情况以及与之相关的各种治疗干预措施。动物模型也受到许多此类问题的限制。大型择期手术解决了许多这些不足,并为探索脓毒症综合征背后的人类生物学提供了一个关键模型。手术引发了人类炎症反应中高度保守的特征,这些特征在组织损伤和感染中都很常见。手术患者脓毒症的发生率可预测且相对较高,尤其是在“高风险”组中。术前样本的采集使每个患者都能作为自己的对照。因此,手术模型提供了独特而精妙的实验设计特点,在动物实验室模型提供的基础生物学理解与人类脓毒症的全新表现之间搭建了一座重要的转化桥梁。

相似文献

1
Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis.人类成为新的小白鼠:择期手术作为多器官功能障碍和脓毒症的关键转化模型。
J Intensive Care Soc. 2015 May;16(2):154-163. doi: 10.1177/1751143714564826. Epub 2015 Jan 7.
2
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
3
Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine.未控制的脓毒症:重症医学中转化免疫学研究的系统评价
Intensive Care Med Exp. 2014 Dec;2(1):6. doi: 10.1186/2197-425X-2-6. Epub 2014 Feb 27.
4
Experimental human endotoxemia as a model of systemic inflammation.实验性人类内毒素血症作为全身炎症模型。
Biochimie. 2019 Apr;159:99-106. doi: 10.1016/j.biochi.2018.06.014. Epub 2018 Jun 22.
5
Why do animal models (sometimes) fail to mimic human sepsis?为什么动物模型(有时)无法模拟人类脓毒症?
Crit Care Med. 2004 May;32(5 Suppl):S219-22. doi: 10.1097/01.ccm.0000127036.27343.48.
6
Sepsis 2019 - New Trends and Their Implications for Multiple Trauma Patients.2019年脓毒症——新趋势及其对多发伤患者的影响
Z Orthop Unfall. 2020 Feb;158(1):81-89. doi: 10.1055/a-0853-2054. Epub 2019 Sep 9.
7
Metabolomic findings in sepsis as a damage of host-microbial metabolism integration.脓毒症中的代谢组学发现:宿主-微生物代谢整合的损伤
J Crit Care. 2018 Feb;43:246-255. doi: 10.1016/j.jcrc.2017.09.014. Epub 2017 Sep 15.
8
Multiple organ dysfunction syndrome: past, present and future.多器官功能障碍综合征:过去、现在与未来
Surg Infect (Larchmt). 2000 Fall;1(3):155-61; discussion 161-3. doi: 10.1089/109629600750018088.
9
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients.美国胸科医师学会/危重病医学会关于严重创伤患者的全身炎症反应综合征及相关病症的共识会议定义
Crit Care Med. 1997 Nov;25(11):1789-95. doi: 10.1097/00003246-199711000-00014.
10
Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.抗生素治疗大肠杆菌猪重症监护脓毒症模型后内毒素、炎症变量和器官功能障碍的动力学。
Crit Care Med. 2018 Jul;46(7):e634-e641. doi: 10.1097/CCM.0000000000003139.

引用本文的文献

1
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.适可而止:在缺乏临床前疗效数据的情况下,将已知药物用于新适应症临床测试的决策标准。
Assay Drug Dev Technol. 2017 Dec;15(8):354-361. doi: 10.1089/adt.2017.821. Epub 2017 Dec 1.
2
Sepsis Patients with First and Second-Hit Infections Show Different Outcomes Depending on the Causative Organism.首次感染和二次感染的脓毒症患者根据致病微生物的不同呈现出不同的结果。
Front Microbiol. 2016 Feb 26;7:207. doi: 10.3389/fmicb.2016.00207. eCollection 2016.

本文引用的文献

1
Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine.未控制的脓毒症:重症医学中转化免疫学研究的系统评价
Intensive Care Med Exp. 2014 Dec;2(1):6. doi: 10.1186/2197-425X-2-6. Epub 2014 Feb 27.
2
A mouse is not a rat is not a man: species-specific metabolic responses to sepsis - a nail in the coffin of murine models for critical care research?小鼠不是大鼠,大鼠也不是人类:脓毒症的物种特异性代谢反应——重症监护研究小鼠模型的致命一击?
Intensive Care Med Exp. 2013 Dec;1(1):26. doi: 10.1186/2197-425X-1-7. Epub 2013 Oct 29.
3
Simvastatin in the acute respiratory distress syndrome.辛伐他汀治疗急性呼吸窘迫综合征。
N Engl J Med. 2014 Oct 30;371(18):1695-703. doi: 10.1056/NEJMoa1403285. Epub 2014 Sep 30.
4
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.严重脓毒症患者晶体液选择与院内死亡率的关系*。
Crit Care Med. 2014 Jul;42(7):1585-91. doi: 10.1097/CCM.0000000000000305.
5
A randomized trial of protocol-based care for early septic shock.一项基于方案的早期脓毒性休克护理的随机试验。
N Engl J Med. 2014 May 1;370(18):1683-93. doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18.
6
Albumin replacement in patients with severe sepsis or septic shock.严重脓毒症或脓毒性休克患者的白蛋白替代治疗。
N Engl J Med. 2014 Apr 10;370(15):1412-21. doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18.
7
High versus low blood-pressure target in patients with septic shock.严重脓毒症及脓毒性休克患者的血压目标:高与低之比较
N Engl J Med. 2014 Apr 24;370(17):1583-93. doi: 10.1056/NEJMoa1312173. Epub 2014 Mar 18.
8
The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.血管加压素和皮质类固醇在感染性休克中的相互作用:一项初步随机对照试验。
Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.
9
The beta agonist lung injury trial prevention. A randomized controlled trial.β受体激动剂肺损伤试验预防。一项随机对照试验。
Am J Respir Crit Care Med. 2014 Mar 15;189(6):674-83. doi: 10.1164/rccm.201308-1549OC.
10
Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*.评估两种剂量的多克隆抗肿瘤坏死因子-α 片段抗体 AZD9773 治疗成人严重脓毒症和/或脓毒性休克患者的疗效和安全性:随机、双盲、安慰剂对照的 IIb 期研究*。
Crit Care Med. 2014 Mar;42(3):504-11. doi: 10.1097/CCM.0000000000000043.